Pharma
What’s next for GLP-1s?
Because who doesn’t prefer swallowing a pill over getting a shot?
Pharma
SPONSORED BY
Pharma
Merck execs say they expect a $200m hit from Trump tariffs
Pharma companies are highlighting their US investments as the government threatens pharmaceutical tariffs.
Pharma
How federal vaccine skepticism could affect public health, pharma industry
“Decades of rigorous global studies involving millions of people have confirmed this science,” one expert said.
Sponsored by Pri-Med
Pharma
Johns Hopkins mRNA researchers rattled by potential cuts
Cuts to research funding could harm efforts to develop a vaccine for pancreatic cancer.
Pharma
State drug-pricing boards are gaining momentum
Experts say more states may follow after judge dismisses Amgen lawsuit.
Pharma
J&J CEO warns against pharmaceutical tariffs
The company expects $400 million in costs this year from already imposed tariffs.
Access hard-to-reach clinicians. With in-office visit restrictions, it can be difficult for pharma reps to connect with clinicians. Here’s the good news: Primary care clinicians are still seeking out the latest healthcare innovations. Pri-Med helps you connect with those hard-to-reach primary care clinicians, both digitally and in person. Read about it here.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
